Novartis, Genentech file suit alleging illegal importation of prescription drug

A sign of Swiss pharmaceutical giant Novartis is seen on the top of a building at Novartis Campus in Basel on Sept. 9, 2025.Novartis, one of the world's largest pharmaceutical companies, and Genentech, a major biotech firm, say they've uncovered a "dangerous scheme" to import their allergy medication from Canada into the U.S. in violation of U.S. Food and Drug Administration regulations.Both are suing SHARx — a so-called alternative funding program — and a Canadian pharmacy over the importation of Xolair, a ...